 No benefit on either function or depression, however, has been seen.As of 2013, low-quality evidence supports the use of bisphosphonates.A 2009 review found "very limited data reviewed showed that bisphosphonates have the potential to reduce pain associated with bone loss in patients with CRPS I, however, at present evidence is not sufficient to recommend their use in practice".